Commentary
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
There has been significant interest in SGLT2 inhibitors (SGLT2i) as novel oral anti-hyperglycemic agents that have been recently approved for the treatment of type 2 diabetes
[...]Shared decision-making, an approach in which clinicians and patients partner to evaluate best available evidence for treatment options, discuss risks and benefits, and make
[...]Chronic kidney disease (CKD) is a growing problem worldwide, and as highlighted in NephMadness 2016, there is a relatively new form of CKD of nontraditional etiology in
[...]What would you think about a drug that has been covered in the New York Times, 60 Minutes, CNN, and Forbes? Surely it’s a blockbuster and cures cancer, prevents heart
[...]The United States Secretary of Health & Human Services, Alex Azar, recently highlighted in a speech at the National Kidney Foundation’s Kidney Patient Summit the fact
[...]An arteriovenous fistula (AVF) is a unique vascular structure leading to distinctive endothelial insults which may contribute to non-maturation or failure of the access. Up
[...]The association between sickle cell disease (SCD) and chronic kidney disease (CKD) is well known. A disease of recurrent vascular occlusion due to sickling red cells, the
[...]In 1984, the United States Congress passed the National Organ Transplant Act that called for a national network to coordinate the procurement and allocation of organs for
[...]Despite our current understanding regarding the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), only one therapy has been approved by the US FDA.
[...]Congo red is synonymous with amyloidosis. The visually stunning apple green birefringence lights up the eyes and minds of pathologists and nephrologists. Like many
[...]
